October 28, 2011
July 3, 2008
From the News Wire: Boys with T1 have higher testosterone
Sex hormone-binding globulin and total testosterone were higher in individuals with childhood-onset diabetes compared with siblings without diabetes, according to results of a new study.
Researchers from the University of Chicago enrolled 48 participants diagnosed with diabetes before age 18 and 47 siblings without diabetes into the Chicago Childhood Diabetes Registry Family Study (age range, 10 to 32; 39% non-Hispanic white; 75% type 1 diabetes; 96% treated with insulin).
http://www.endocrinetoday.com/view.aspx?rid=29321
Maybe there is somthing to calling Dr Freud after all.
July 2, 2008
From The News Wire: MicroIslet Insulin Encapsulation Update
Company Invents New, Enhanced, Encapsulation Formulation
SAN DIEGO--(BUSINESS WIRE)--MicroIslet Inc. (OTCBB: MIIS, http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for diabetes, is pleased to report recent safety and efficacy data.
To date, MicroIslet has seen no adverse events attributable to MicroIslet-P™ in its animal models. The Company has tested hundreds of rodents and is currently completing a trial with nineteen non-human primates. Eighteen of the nineteen have been tested, and the last primate has received its final dose. Importantly, the primates have been subjected to one, two, or even three, separate transplant procedures, with no observed ill effects.
MicroIslet also has efficacy data demonstrating that MicroIslet-P™ can produce normoglycemia in both immune comprised and immune competent rodents. Additionally, all primates tested to date, post-implant, have demonstrated decreases in insulin requirements needed to maintain their blood glucose levels at a healthy concentration. Finally, post-implant, the primates have been primarily managed with long-acting insulin as opposed to acute insulin treatment, indicating improved glucose homeostasis (control).
MicroIslet is now in the process of patenting a new, enhanced, encapsulation formulation, which is being used in a current Good Laboratory Practices (GLP) rodent toxicity trial, and is the Company’s intended formulation for use in its planned human trial. The improved capsules appear to be not only more durable, but they also retain, and may increase, the positive functionality characteristics of previous formulations. Accordingly, MicroIslet believes that the new formulation will enable: (a) a greater decrease in insulin requirements, (b) better blood glucose control, and (c) increased capsule longevity.
http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20080702005426&newsLang=en
July 1, 2008
From The News Wire: Animas Announces "Ping"
Animas Corporation announced today the clearance of its OneTouch ® Ping TM Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.
“OneTouch Ping provides patients the advanced insulin pump technology from Animas plus the OneTouch blood glucose technology they trust, put together into a system that offers the discretion, convenience and option of remote insulin dosing," said Juan Frias, M.D., Chief Medical Officer and Vice President of Medical Affairs, Animas Corporation. “People using OneTouch Ping will no longer have to access their pump to deliver a bolus, ultimately making life with diabetes a little easier.”
Also and this I am sure is what they weren't talking about when I bent their ear about ezManager (anyone think they will send me a review copy? yeah me neither)
ezManager® MAX Diabetes Management Software The OneTouch Ping system will also work with the recently cleared ezManager® MAX Diabetes Management software designed to allow users to download important diabetes management data from the insulin pump and meter-remote. Integrated blood glucose data from the meter-remote and insulin dosing data may be downloaded for review, analysis and evaluation of insulin delivery and blood glucose history to better inform healthcare decision-making. The ezManager® MAX software is MAC and PC compatible.
I guess this explains the hits to YDMV I saw coming out of J&J on google searches for Animas and Ping recently.
Oh and anyone other than me a Monty Python fan? The Machine that goes "Ping!" LOL
It looks like Ping is a New Pump (see the picture on their web site) It doesn't look like a 2020.
Or look here -
Posts
